Cargando…

Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-Analysis

Cardiac natriuretic peptides (NPs) play a fundamental role in maintaining cardiovascular (CV) and renal homeostasis. Moreover, they also affect glucose and lipid metabolism. We performed a systematic review and meta-analysis of studies investigating the association of NPs with serum lipid profile. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spannella, Francesco, Giulietti, Federico, Bordicchia, Marica, Burnett, John C., Sarzani, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915780/ https://www.ncbi.nlm.nih.gov/pubmed/31844088 http://dx.doi.org/10.1038/s41598-019-55680-z

Ejemplares similares

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
por: Sarzani, Riccardo, et al.
Publicado: (2017)

Role of Cardiac Natriuretic Peptides in Heart Structure and Function
por: Sarzani, Riccardo, et al.
Publicado: (2022)

PCSK9 is Expressed in Human Visceral Adipose Tissue and Regulated by Insulin and Cardiac Natriuretic Peptides
por: Bordicchia, Marica, et al.
Publicado: (2019)

Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded “Double-Trouble” Lipid Profile in Overweight/Obese
por: Spannella, Francesco, et al.
Publicado: (2019)

Effect of sacubitril/valsartan on renal function: a systematic review and meta‐analysis of randomized controlled trials
por: Spannella, Francesco, et al.
Publicado: (2020)

Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Inversely Associated with N-Terminal Pro B-Type Natriuretic Peptide in Older Men and Women
por: Spannella, Francesco, et al.
Publicado: (2022)

Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient
por: Sarzani, Riccardo, et al.
Publicado: (2022)

Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
por: Sarzani, Riccardo, et al.
Publicado: (2020)

Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence
por: Sarzani, Riccardo, et al.
Publicado: (2021)

Painful and recurring injection site reaction to alirocumab and evolocumab in a young woman with familial hypercholesterolemia and effective therapeutic alternative based on inclisiran: a case report
por: Allevi, Massimiliano, et al.
Publicado: (2023)

A 95-year-old patient with unexpected coronavirus disease 2019 masked by aspiration pneumonia: a case report
por: Spannella, Francesco, et al.
Publicado: (2020)

Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice
por: Giulietti, Federico, et al.
Publicado: (2020)

Renal effects of Sacubitril/Valsartan in heart failure with reduced ejection fraction: a real life 1-year follow-up study
por: Spannella, Francesco, et al.
Publicado: (2019)

The Identikit of Patient at Risk for Severe COVID-19 and Death: The Dysregulation of Renin-Angiotensin System as the Common Theme
por: Sarzani, Riccardo, et al.
Publicado: (2021)

Prevalence and predictors of subclinical atrial fibrillation in hospitalized older adults
por: Spannella, Francesco, et al.
Publicado: (2021)

The Number of Pills, Rather Than the Type of Renin–Angiotensin System Inhibitor, Predicts Ambulatory Blood Pressure Control in Essential Hypertensives on Triple Therapy: A Real-Life Cross-Sectional Study
por: Sarzani, Riccardo, et al.
Publicado: (2021)

NT-proBNP and Its Correlation with In-Hospital Mortality in the Very Elderly without an Admission Diagnosis of Heart Failure
por: Sarzani, Riccardo, et al.
Publicado: (2016)

Renin-Angiotensin-System Inhibitors Are Associated With Lower In-hospital Mortality in COVID-19 Patients Aged 80 and Older
por: Spannella, Francesco, et al.
Publicado: (2022)

Chronic Kidney Disease Is Characterized by “Double Trouble” Higher Pulse Pressure plus Night-Time Systolic Blood Pressure and More Severe Cardiac Damage
por: Fedecostante, Massimiliano, et al.
Publicado: (2014)

Innovative Therapeutics: Designer Natriuretic Peptides
por: Meems, Laura M.G., et al.
Publicado: (2016)

Chronic natriuretic peptide protein therapeutics
por: Chen, Horng H, et al.
Publicado: (2013)

Radiological lung sequelae, functional status and symptoms in older patients 3 and 6 months after hospitalization for COVID-19 pneumonia
por: Di Pentima, Chiara, et al.
Publicado: (2023)

Heart hormones fueling a fire in fat
por: Collins, Sheila, et al.
Publicado: (2013)

Role of Cardio-Renal Dysfunction, Inflammation Markers, and Frailty on In-Hospital Mortality in Older COVID-19 Patients: A Cluster Analysis
por: Spannella, Francesco, et al.
Publicado: (2023)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

C-type natriuretic peptide: the heart’s guardian angel
por: Sangaralingham, S Jeson, et al.
Publicado: (2020)

Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease
por: Cannone, Valentina, et al.
Publicado: (2019)

NATRIURETIC PEPTIDE SYSTEM AND CARDIOVASCULAR DISEASE
por: Federico, Cacciapuoti
Publicado: (2010)

Atrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in Humans
por: Birkenfeld, Andreas L., et al.
Publicado: (2008)

C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function
por: Buttgereit, Jens, et al.
Publicado: (2016)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Arterial Remodeling in B-Type Natriuretic Peptide Knock-Out Females
por: Holditch, Sara J., et al.
Publicado: (2016)

Novel roles of cardiac natriuretic peptides in renal compensatory hypertrophy
por: Schreiber, Andrea, et al.
Publicado: (2015)

Natriuretic peptide and cardiac troponin levels in doxorubicin-induced cardiotoxicity
por: Gülgün, Mustafa, et al.
Publicado: (2016)

The Endocrine Heart: Natriuretic Peptides and Oxygen Metabolism in Cardiac Diseases
por: Arjamaa, Olli
Publicado: (2021)

Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A
por: Vink, Simone, et al.
Publicado: (2023)

Cardiac Natriuretic Peptide Profiles in Chronic Hypertension by Single or Sequentially Combined Renovascular and DOCA-Salt Treatments
por: Cerrudo, Carolina S., et al.
Publicado: (2021)

Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis
por: Lin, Kuan-Ho, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f61ieje3l15knuaoua2lj9qkue